SEI Investments
ACOR

SEI Investments’s Acorda Therapeutics ACOR Stock Holding History

SEI Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-605
Closed -$37K – 2555
2020
Q3 		$37K Sell
605
-442
-42% -$33.3K ﹤0.01% 2382
2020
Q2 		$92K Hold
1,047
– – ﹤0.01% 2325
2020
Q1 		$117K Hold
1,047
– – ﹤0.01% 2233
2019
Q4 		$256K Hold
1,047
– – ﹤0.01% 2197
2019
Q3 		$361K Buy
1,047
+160
+18% +$87K ﹤0.01% 2041
2019
Q2 		$817K Sell
887
-16
-2% -$19.7K ﹤0.01% 1659
2019
Q1 		$1.44M Buy
903
+307
+52% +$553K ﹤0.01% 1447
2018
Q4 		$1.4M Hold
596
– – 0.01% 1422
2018
Q3 		$1.4M Buy
596
+595
+59,500% +$1.84M 0.01% 1368
2018
Q2 		$2K Sell
1
-5
-83% -$15.3K ﹤0.01% 3393
2018
Q1 		$16K Buy
+6
New +$18K ﹤0.01% 2727
2017
Q3 		– Hold
0
– – – 3451
2017
Q2 		– Sell
-773
Closed -$1.53M – 3343
2017
Q1 		$1.95M Buy
773
+8
+1% +$23K 0.01% 1170
2016
Q4 		$1.73M Buy
765
+139
+22% +$330K 0.01% 1197
2016
Q3 		$1.57M Buy
626
+9
+1% +$26.9K 0.01% 1150
2016
Q2 		$1.89M Buy
617
+47
+8% +$153K 0.01% 1013
2016
Q1 		$1.81M Buy
570
+37
+7% +$154K 0.01% 991
2015
Q4 		$2.73M Sell
533
-85
-14% -$371K 0.02% 880
2015
Q3 		$1.97M Buy
618
+319
+107% +$1.24M 0.02% 808
2015
Q2 		$1.2M Buy
299
+9
+3% +$34.8K 0.01% 929
2015
Q1 		$1.16M Buy
+290
New +$1.33M 0.01% 925

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SEI Investments's ACOR Position: Q4 2020 in Review

SEI Investments sold out of Acorda Therapeutics (ACOR) in Q4 2020, closing a stake of 605 shares — an estimated $37K sold.

SEI Investments first reported a position in ACOR in Q1 2015 and held it in 20 quarters. The position peaked at $2.73M in Q4 2015. 47 funds tracked by Wall St. Rank hold ACOR as of Q4 2020.

  • SEI Investments reported no remaining Acorda Therapeutics position as of Q4 2020 after selling out during the quarter.
  • SEI Investments sold 605 Acorda Therapeutics shares in Q4 2020, an estimated $37K.
  • SEI Investments first reported a position in Acorda Therapeutics in Q1 2015 and held it in 20 quarters.
  • SEI Investments's Acorda Therapeutics position peaked at $2.73M in Q4 2015.
  • 47 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.